Cargando…
Adipocytes promote ovarian cancer chemoresistance
Ovarian cancer (OvCa), while accounting for only 3% of all women’s cancer, is the fifth leading cause of cancer death among women. One of the most significant obstacles to successful OvCa treatment is chemoresistance. The current lack of understanding of the driving mechanisms underlying chemoresist...
Autores principales: | Yang, Jiang, Zaman, Munir M., Vlasakov, Iliyan, Roy, Roopali, Huang, Lan, Martin, Camilia R., Freedman, Steven D., Serhan, Charles N., Moses, Marsha A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746782/ https://www.ncbi.nlm.nih.gov/pubmed/31527632 http://dx.doi.org/10.1038/s41598-019-49649-1 |
Ejemplares similares
-
Late Enteral Feedings Are Associated with Intestinal Inflammation and Adverse Neonatal Outcomes
por: Konnikova, Yelizaveta, et al.
Publicado: (2015) -
Prognostic role of ultrasonography staging in patients with anal cancer
por: De Nardi, Paola, et al.
Publicado: (2020) -
Adipocyte‐Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer
por: Zhang, Qiumo, et al.
Publicado: (2022) -
Resolvin D1 and Lipoxin A(4) Improve Alveolarization and Normalize Septal Wall Thickness in a Neonatal Murine Model of Hyperoxia-Induced Lung Injury
por: Martin, Camilia R., et al.
Publicado: (2014) -
The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP
por: Zhu, Xiaolin, et al.
Publicado: (2021)